• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗给药的描述:选择与陷阱

The description of chemotherapy delivery: options and pitfalls.

作者信息

Coppin C M

机构信息

Division of Medical Oncology, University of British Columbia, Vancouver, Canada.

出版信息

Semin Oncol. 1987 Dec;14(4 Suppl 4):34-42.

PMID:3686045
Abstract

Delivered and planned drug doses in chemotherapy trials are analyzed in relation to dose size, dose rate, and total drug delivery. Time-dose factors are presented in different ways, further exploring what may be misleading when comparing one treatment program with another. The time frame over which treatment intensity is to be calculated is recognized as arbitrary and not necessarily from start to end of treatment. Considerations for doses missed are presented. The cumulative-dose plot represents a new method of data presentation. This method graphically captures both intensity and total drug delivery per patient, and is helpful when analyzing trials designed to isolate treatment variables and improve the therapeutic index of available drugs.

摘要

对化疗试验中已给药和计划给药剂量进行分析,涉及剂量大小、剂量率和总药物输送量。时间 - 剂量因素以不同方式呈现,进一步探讨在比较不同治疗方案时可能产生误导的因素。计算治疗强度的时间范围被认为是任意的,不一定是从治疗开始到结束。文中还给出了对漏服剂量的考量。累积剂量图代表了一种新的数据呈现方法。这种方法以图形方式反映了每位患者的治疗强度和总药物输送量,在分析旨在分离治疗变量并提高现有药物治疗指数的试验时很有帮助。

相似文献

1
The description of chemotherapy delivery: options and pitfalls.化疗给药的描述:选择与陷阱
Semin Oncol. 1987 Dec;14(4 Suppl 4):34-42.
2
Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.多柔比星/紫杉醇/环磷酰胺序贯辅助治疗累及四个或更多腋窝淋巴结的可切除乳腺癌。
Semin Oncol. 1995 Dec;22(6 Suppl 15):18-23.
3
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.剂量递增的环磷酰胺、多柔比星、长春新碱和泼尼松(CHOP)方案联合依托泊苷(超大剂量CHOEP)4个疗程与6个疗程以及自体干细胞移植:早期剂量强度对治疗预后不良的年轻侵袭性淋巴瘤患者至关重要。
Cancer. 2006 Jan 1;106(1):136-45. doi: 10.1002/cncr.21588.
4
Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.多柔比星与环磷酰胺、甲氨蝶呤和氟尿嘧啶不同给药顺序在可手术乳腺癌中的临床相关性
J Clin Oncol. 2004 May 1;22(9):1614-20. doi: 10.1200/JCO.2004.07.190.
5
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.转移性乳腺癌患者接受剂量密集型阿霉素/紫杉醇/环磷酰胺联合外周血祖细胞及细胞因子支持的I/II期研究。
Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-77-S17-80.
6
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.对于初治转移性乳腺癌,先进行短疗程诱导化疗,然后进行两个周期的高剂量化疗并联合干细胞救援。
Bone Marrow Transplant. 2001 Feb;27(3):269-78. doi: 10.1038/sj.bmt.1702780.
7
[Use of adriamycin in the treatment of metastatic breast cancer].[阿霉素在转移性乳腺癌治疗中的应用]
Vopr Onkol. 1984;30(6):67-73.
8
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.多柔比星序贯紫杉醇和环磷酰胺与紫杉醇和环磷酰胺同步给药的比较:一项针对淋巴结阳性乳腺癌女性辅助剂量密集化疗的II期随机试验的5年结果
Clin Cancer Res. 2001 Dec;7(12):3934-41.
9
[Relation dose efficacy in chemotherapy: the example of breast cancer].[化疗中的剂量疗效关系:以乳腺癌为例]
Bull Cancer. 1995;82 Suppl 1:9s-15s.
10
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens.在乳腺癌辅助化疗中,多柔比星和环磷酰胺联合粒细胞集落刺激因子及外周血干细胞时剂量强度的调整:三种强化方案的完成情况和安全性比较评估
Bone Marrow Transplant. 2002 Jun;29(11):881-6. doi: 10.1038/sj.bmt.1703556.

引用本文的文献

1
A trial of individual dose intensity and relative performance factors in tegafur maintenance chemotherapy for head and neck cancer.
Eur Arch Otorhinolaryngol. 1993;250(7):408-11. doi: 10.1007/BF00180387.
2
Continuous versus intermittent prednimustine treatment of non-Hodgkin's lymphoma.
Med Oncol Tumor Pharmacother. 1993;10(4):159-66. doi: 10.1007/BF02989664.
3
Dose intensity in cancer chemotherapy.癌症化疗中的剂量强度。
Br J Cancer. 1990 Jun;61(6):789-94. doi: 10.1038/bjc.1990.178.
4
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Drugs. 1992 Jul;44(1):1-8. doi: 10.2165/00003495-199244010-00001.
5
Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples.以小细胞肺癌治疗方案为例计算联合用药的接受剂量强度。
Cancer Chemother Pharmacol. 1992;30(3):199-206. doi: 10.1007/BF00686312.